Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lev

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|February 20, 1999
Isolated limb perfusion with high-dose tumor necrosis factor alpha and melphalan for Kaposi sarcomaD Lev-Chelouche, S Abu-Abeid, O Merimsky, et al.
Cancer|March 15, 1997
High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservationM Gutman, M Inbar, D Lev-Shlush, et al.
Journal of Child Neurology|January 21, 2000
Neurologic presentations of mitochondrial disordersA Nissenkorn, A Zeharia, D Lev, et al.
Biochemical and Biophysical Research Communications|July 19, 2005
Fulminant neurological deterioration in a neonate with Leigh syndrome due to a maternally transmitted missense mutation in the mitochondrial ND3 geneE Leshinsky-Silver, D Lev, Z Tzofi-Berman, et al.
Harefuah|October 1, 1996
[Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs]S Abu-Abid, M Gutman, D Lev, et al.
Journal of Environmental Radioactivity|February 6, 2018
Preventive radioecological assessment of territory for optimization of monitoring and countermeasures after radiation accidentsB S Prister, V D Vinogradskaya, T D Lev, et al.
Cancer|September 1, 1996
Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancerM Gutman, S Abu-Abid, P Sorkine, et al.
Pediatric Cardiology|June 9, 2004
Clinical presentations of mitochondrial cardiomyopathiesD Lev, A Nissenkorn, E Leshinsky-Silver, et al.
Oncology|January 11, 2001
Is forequarter amputation justified for palliation of intractable cancer symptoms?O Merimsky, Y Kollender, M Inbar, et al.
Neuromuscular Disorders : NMD|September 11, 2007
Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin geneE Leshinsky-Silver, Z Argov, L Rozenboim, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Archives of Surgery (Chicago, Ill. : 1960)|February 20, 1999
Isolated limb perfusion with high-dose tumor necrosis factor alpha and melphalan for Kaposi sarcomaD Lev-Chelouche, S Abu-Abeid, O Merimsky, et al.
Cancer|March 15, 1997
High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservationM Gutman, M Inbar, D Lev-Shlush, et al.
Journal of Child Neurology|January 21, 2000
Neurologic presentations of mitochondrial disordersA Nissenkorn, A Zeharia, D Lev, et al.
Biochemical and Biophysical Research Communications|July 19, 2005
Fulminant neurological deterioration in a neonate with Leigh syndrome due to a maternally transmitted missense mutation in the mitochondrial ND3 geneE Leshinsky-Silver, D Lev, Z Tzofi-Berman, et al.
Harefuah|October 1, 1996
[Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs]S Abu-Abid, M Gutman, D Lev, et al.
Journal of Environmental Radioactivity|February 6, 2018
Preventive radioecological assessment of territory for optimization of monitoring and countermeasures after radiation accidentsB S Prister, V D Vinogradskaya, T D Lev, et al.
Cancer|September 1, 1996
Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancerM Gutman, S Abu-Abid, P Sorkine, et al.
Pediatric Cardiology|June 9, 2004
Clinical presentations of mitochondrial cardiomyopathiesD Lev, A Nissenkorn, E Leshinsky-Silver, et al.
Oncology|January 11, 2001
Is forequarter amputation justified for palliation of intractable cancer symptoms?O Merimsky, Y Kollender, M Inbar, et al.
Neuromuscular Disorders : NMD|September 11, 2007
Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin geneE Leshinsky-Silver, Z Argov, L Rozenboim, et al.
Pageof 13